HK1061230A1 - Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride nad glycine chloride - Google Patents

Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride nad glycine chloride

Info

Publication number: HK1061230A1
Authority: HK; Hong Kong
Prior art keywords: chloride; carnitine; alkanoyl; solid compositions; oral administration
Prior art date: 2000-10-31

Application number

HK04104342A

Other languages

English (en)

Inventor

Maria Ornella Tinti

Original Assignee

Sigma Tau Ind Farmaceuti

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-31

Filing date

2004-06-16

Publication date

2004-09-10

2004-06-16 Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti

2004-09-10 Publication of HK1061230A1 publication Critical patent/HK1061230A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hematology (AREA)
Botany (AREA)
Mycology (AREA)
Obesity (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Neurosurgery (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Child & Adolescent Psychology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Fodder In General (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

HK04104342A 2000-10-31 2004-06-16 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride nad glycine chloride HK1061230A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT2000RM000567A IT1317924B1 (it)	2000-10-31	2000-10-31	Composizioni solide atte alla somministrazione orale comprendenti salinon igroscopici della l-carnitina e delle alcanoil l-carnitine con
PCT/IT2001/000503 WO2002036543A1 (en)	2000-10-31	2001-09-28	Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride

Publications (1)

Publication Number	Publication Date
HK1061230A1 true HK1061230A1 (en)	2004-09-10

Family

ID=11454973

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK04104342A HK1061230A1 (en)	2000-10-31	2004-06-16	Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride nad glycine chloride

Country Status (25)

Country	Link
US (1)	US7858820B2 (zh)
EP (1)	EP1330428B1 (zh)
JP (1)	JP4181406B2 (zh)
KR (1)	KR100764155B1 (zh)
CN (1)	CN1219748C (zh)
AT (1)	ATE312810T1 (zh)
AU (2)	AU9589301A (zh)
BR (1)	BRPI0115019B1 (zh)
CA (1)	CA2427482C (zh)
CY (1)	CY1106062T1 (zh)
CZ (1)	CZ302802B6 (zh)
DE (1)	DE60115944T2 (zh)
DK (1)	DK1330428T3 (zh)
ES (1)	ES2253430T3 (zh)
HK (1)	HK1061230A1 (zh)
HU (1)	HU229989B1 (zh)
IT (1)	IT1317924B1 (zh)
MX (1)	MXPA03003799A (zh)
NZ (1)	NZ525333A (zh)
PL (1)	PL205801B1 (zh)
RU (1)	RU2270191C2 (zh)
SI (1)	SI1330428T1 (zh)
SK (1)	SK287133B6 (zh)
WO (1)	WO2002036543A1 (zh)
ZA (1)	ZA200303328B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102005031705A1 (de) *	2005-07-05	2007-01-18	Henkel Kgaa	Mittel, enthaltend L-Carnitin oder L-Carnitinderivate und mindestens eine weitere Substanz ausgewählt aus Taurin und dessen Derivaten und mindestens einem Wirkstoff, erhältlich aus Pflanzen der Gattung Echinacea
KR101007927B1 (ko)	2008-12-24	2011-01-14	주식회사 셀트리온제약	시부트라민-ｌ-카르니틴 다이술폰산염, 이의 제조방법 및 이를 포함하는 약제학적 조성물
JP5451558B2 (ja) *	2010-08-27	2014-03-26	シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ	美容活性成分の送達に有用なゲル
CN104276986B (zh) *	2013-07-12	2016-07-06	辽宁科硕营养科技有限公司	左旋肉碱牛磺酸盐的制备方法
JP6473352B2 (ja) *	2015-03-10	2019-02-20	利幸糸井	虚血性疾患治療薬
CN107325013B (zh) *	2016-04-28	2019-04-12	辽宁科硕营养科技股份有限公司	一种合成甘氨酸丙酰左旋肉碱盐酸盐的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3463261D1 (en) *	1983-12-28	1987-05-27	Sigma Tau Ind Farmaceuti	Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same
CA2030310A1 (en) *	1989-12-22	1991-06-23	Ronald E. Macleay	Derivatives of n-hals-substituted amic acid hydrazides
IT1291126B1 (it) *	1997-04-01	1998-12-29	Sigma Tau Ind Farmaceuti	Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine
IT1306147B1 (it) *	1999-05-28	2001-05-30	Biosalts Srl	Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali

2000
- 2000-10-31 IT IT2000RM000567A patent/IT1317924B1/it active
2001
- 2001-09-28 AT AT01976633T patent/ATE312810T1/de active
- 2001-09-28 SK SK501-2003A patent/SK287133B6/sk not_active IP Right Cessation
- 2001-09-28 EP EP01976633A patent/EP1330428B1/en not_active Expired - Lifetime
- 2001-09-28 CN CNB018182941A patent/CN1219748C/zh not_active Expired - Lifetime
- 2001-09-28 CA CA2427482A patent/CA2427482C/en not_active Expired - Fee Related
- 2001-09-28 US US10/415,472 patent/US7858820B2/en not_active Expired - Lifetime
- 2001-09-28 AU AU9589301A patent/AU9589301A/xx active Pending
- 2001-09-28 DE DE60115944T patent/DE60115944T2/de not_active Expired - Lifetime
- 2001-09-28 DK DK01976633T patent/DK1330428T3/da active
- 2001-09-28 MX MXPA03003799A patent/MXPA03003799A/es active IP Right Grant
- 2001-09-28 ES ES01976633T patent/ES2253430T3/es not_active Expired - Lifetime
- 2001-09-28 AU AU2001295893A patent/AU2001295893B2/en not_active Ceased
- 2001-09-28 JP JP2002539304A patent/JP4181406B2/ja not_active Expired - Fee Related
- 2001-09-28 RU RU2003116133/04A patent/RU2270191C2/ru active
- 2001-09-28 SI SI200130462T patent/SI1330428T1/sl unknown
- 2001-09-28 WO PCT/IT2001/000503 patent/WO2002036543A1/en active IP Right Grant
- 2001-09-28 NZ NZ525333A patent/NZ525333A/en not_active IP Right Cessation
- 2001-09-28 KR KR1020037005596A patent/KR100764155B1/ko active IP Right Grant
- 2001-09-28 HU HU0302294A patent/HU229989B1/hu not_active IP Right Cessation
- 2001-09-28 BR BRPI0115019A patent/BRPI0115019B1/pt not_active IP Right Cessation
- 2001-09-28 CZ CZ20031041A patent/CZ302802B6/cs not_active IP Right Cessation
- 2001-09-28 PL PL364823A patent/PL205801B1/pl unknown
2003
- 2003-04-30 ZA ZA200303328A patent/ZA200303328B/en unknown
2004
- 2004-06-16 HK HK04104342A patent/HK1061230A1/xx not_active IP Right Cessation
2006
- 2006-01-19 CY CY20061100074T patent/CY1106062T1/el unknown

Also Published As

Publication number	Publication date
US7858820B2 (en)	2010-12-28
RU2270191C2 (ru)	2006-02-20
US20040024061A1 (en)	2004-02-05
BR0115019A (pt)	2003-12-23
DE60115944D1 (de)	2006-01-19
KR20030059211A (ko)	2003-07-07
JP2004513107A (ja)	2004-04-30
JP4181406B2 (ja)	2008-11-12
AU2001295893B2 (en)	2006-11-30
CA2427482C (en)	2010-04-27
ZA200303328B (en)	2004-03-09
SI1330428T1 (sl)	2006-04-30
CN1219748C (zh)	2005-09-21
HU229989B1 (hu)	2015-04-28
KR100764155B1 (ko)	2007-10-08
ATE312810T1 (de)	2005-12-15
NZ525333A (en)	2004-06-25
BRPI0115019B1 (pt)	2015-10-06
DE60115944T2 (de)	2006-06-29
CN1473144A (zh)	2004-02-04
WO2002036543A1 (en)	2002-05-10
PL364823A1 (en)	2004-12-27
PL205801B1 (pl)	2010-05-31
DK1330428T3 (da)	2006-04-18
IT1317924B1 (it)	2003-07-15
ES2253430T3 (es)	2006-06-01
CZ20031041A3 (cs)	2003-08-13
CY1106062T1 (el)	2011-06-08
EP1330428B1 (en)	2005-12-14
MXPA03003799A (es)	2004-04-20
ITRM20000567A0 (it)	2000-10-31
CA2427482A1 (en)	2002-05-10
HUP0302294A3 (en)	2005-05-30
EP1330428A1 (en)	2003-07-30
HUP0302294A2 (hu)	2003-10-28
SK5012003A3 (en)	2003-11-04
CZ302802B6 (cs)	2011-11-16
AU9589301A (en)	2002-05-15
SK287133B6 (sk)	2010-01-07
ITRM20000567A1 (it)	2002-05-01

Publication	Publication Date	Title
WO1996017587A3 (en)	1996-08-22	Oral compositions containing stabilized stannous compounds
ES2173400T3 (es)	2002-10-16	Composiciones que contienen cinc para administracion oral que incluyen un compuesto de cobre y un aminoacido.
HK1046374A1 (en)	2003-01-10	Camptothecin analogs and methods of preparation thereof
ES2099022A1 (es)	1997-05-01	Composiciones farmaceuticas que contienen las sales de acido s(+)-2-(4-isobutilfenil) propionico con aminoacidos basicos.
JO2099B1 (en)	2000-05-21	Anti-allergic sedative syrup
MY125414A (en)	2006-07-31	Aminopropylphosphinic acids
AU3458395A (en)	1996-05-09	Salts of nefazodone having improved dissolution rates
DE60331319D1 (de)	2010-04-01	Nahrungs- oder pharmazeutische zusammensetzungen zur erhöhung der creatin-antwort von organismen
WO1992019617A3 (en)	1992-12-10	Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
HK1061230A1 (en)	2004-09-10	Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride nad glycine chloride
DK1095015T3 (da)	2005-09-12	Sulfonylamino-carboxylsyre-N-arylamider som aktivatorer for guanylatcyclase
HRP20030002A2 (en)	2005-10-31	STABLE GABAPENTIN HAVING pH WITHIN A CONTROLLED RANGE
BR9915692A (pt)	2001-08-14	Monohidrato de bromidrato de eletriptano
PL367812A1 (en)	2005-03-07	Alpha-ketoglutarates of active ingredients and compositions containing same
IL140487A0 (en)	2002-02-10	Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and alkanoyl l-carnitines
NZ507407A (en)	2002-08-28	Stable mitoxantrone solutions
HK1047084A1 (en)	2003-02-07	Therapeutically and/or nutritionally enhanced derivatives of active ingredients and orally administrable compositions containing same.
AU6725300A (en)	2001-04-10	Non-hygroscopic salts of active ingredients having therapeutical and/or nutritional activities and orally administrable compositions containing same
ES2167878T3 (es)	2002-05-16	Composiciones solidas apropiadas para administracion oral que comprenden sales no higroscopicas de l-carnitina y alcanoil-l-carnitina con acido 2-aminoetansulfonico.
AR008764A1 (es)	2000-02-23	Sales hidratadas de n,n'-diacetilcistina, proceso para su preparacion, y composiciones terapeuticas que comprenden a dichas sales como ingredienteactivo.

Legal Events

Date	Code	Title	Description
2021-10-08	PE	Patent expired	Effective date: 20210927